Organogenesis Holdings (ORGO) Retained Earnings (2015 - 2026)

Organogenesis Holdings' Retained Earnings history runs 12 years deep, the most recent figure standing at -$56.2 million for Q1 2026.

• In Q1 2026, Retained Earnings rose 4.61% year-over-year to -$56.2 million; the TTM figure through Mar 2026 stood at -$56.2 million (up 4.61% YoY), while the FY2025 annual figure was -$3.1 million, up 92.33% from the prior year.
• Retained Earnings was -$56.2 million for Q1 2026 at Organogenesis Holdings, down from -$3.1 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$3.1 million in Q4 2025 to a low of -$68.3 million in Q2 2025.
• Historically, Retained Earnings has averaged -$47.7 million across 5 years, with a median of -$47.8 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Retained Earnings sank 37.97% in 2024, then jumped 92.33% in 2025.
• A 5-year view of Retained Earnings shows it stood at -$45.3 million in 2022, then rose by 9.56% to -$41.0 million in 2023, then climbed by 2.1% to -$40.1 million in 2024, then surged by 92.33% to -$3.1 million in 2025, then sank by 1726.97% to -$56.2 million in 2026.
• The last three Retained Earnings figures came in at -$56.2 million (Q1 2026), -$3.1 million (Q4 2025), and -$46.8 million (Q3 2025), per Business Quant data.